Phase 1/2 study of SIR-Spheres plus systemic chemotherapy with 5-fluorouracil, leucovorin and oxaliplatin in patients with liver metastases from colorectal carcinoma

ABSTRACT: Interventions: The study is a multi-centre phase I/II dose-escalation study that aims to assess the safety and efficacy of a single implantation of SIR-Spheres when used in combination with systemic chemotherapy with FOLFOX4. Toxicity will be assessed after 3 cycles of treatment, at which stage the oxaliplatin will be escalated to full dose and the patients will go on receive a maximum of 12 cycles of chemotherapy. (The duration of the treatment cycles varies as it is based on the doctor’s discretion. Ideally the treatment cycles would be 1 week of treatment and then 1 week of rest.) Primary outcome(s): Toxicity[Assessed using standard UICC criteria which will be assessed after patients have completed 12 cycles of chemotherapy.] Study Design: Purpose: Treatment; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group;Type of endpoint: Safety/efficacy

DISEASE(S): Cancer-bowel-back Passage (rectum) Or Large Bowel (colon),Unresectable Liver Metastases From Colorectal Carcinoma,Cancer-liver

PROVIDER: 2452613 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR